Overview
Keith Flaherty is an Oncologist in Boston, Massachusetts. Dr. Flaherty is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, Tissue Biopsy, and Nephrectomy. Dr. Flaherty is currently accepting new patients.
His clinical research consists of co-authoring 434 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 21 articles and participated in 2 clinical trials in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Dana-Farber Cancer Institute, Inc.
Toni Choueiri is an Oncologist in Milford, Massachusetts. Dr. Choueiri is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Bradley Mcgregor is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Mcgregor is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Muscle Invasive Bladder Cancer, Tissue Biopsy, and Nephrectomy. Dr. Mcgregor is currently accepting new patients.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
David Mcdermott is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Flaherty isElite. Learn about Melanoma.
- Advanced
- Melanoma of the EyeDr. Flaherty isAdvanced. Learn about Melanoma of the Eye.
- Renal Cell Carcinoma (RCC)Dr. Flaherty isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- Adult Soft Tissue SarcomaDr. Flaherty isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Flaherty isExperienced. Learn about Agranulocytosis.
- AstrocytomaDr. Flaherty isExperienced. Learn about Astrocytoma.
- Bladder CancerDr. Flaherty isExperienced. Learn about Bladder Cancer.
- Brain TumorDr. Flaherty isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Flaherty isExperienced. Learn about Breast Cancer.